| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae84948901b77f34fd51c41264d8d19c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| filingDate |
2005-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42fa3180f3a7c7e1926b3351a47771d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5e55b395f1ec7ff6f49d8869f2090e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2dcd33c4349b39922e4fd97d0aad2836 |
| publicationDate |
2006-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-200603793-A |
| titleOfInvention |
Oral sustained release formulation of tedisamil with gastric retention properties |
| abstract |
The present invention relates to a novel sustained release formulation with gastric retention properties comprising tedisamil or a pharmaceutically acceptable salt thereof and the use of this formulation in the prevention and treatment of atrial fibrillation, atrial flutter and cardiac ischemia. |
| priorityDate |
2004-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |